Abstract:There is increasing evidence that mesenchymal stem cells (MSCs) derived from different tissues could act as an alternative source of mature hepatocytes for treatment of acute liver failure (ALF). Human umbilical cord matrix stem cells (hUCMSCs) represent a novel source of MSCs. We examined the therapeutic potential and the different mechanisms of hUCMSCs by their transplantation into nonobese diabetic severe combined-immunodeficient (NOD-SCID) mice with carbon tetrachloride (CCl4)-induced ALF in comparison to adult human hepatocytes (AHHs). The characteristics of isolated hUCMSCs were determined from MSCs and hepatocyte marker expression, hepatic function, and differentiation. Native hUCMSCs constitutively expressed some hepatic markers, though weaker hepatocyte-specific functions were observed when compared to AHHs. When native hUCMSCs or AHHs were transplanted into livers of NOD-SCID mice with ALF induced by CCl4, both hUCMSCs and AHHs provided a significant survival benefit and prevented the release of liver injury biomarkers. hUCMSCs were found to engraft within the recipient liver and differentiated into functional hepatocytes, whereas the HepPar1-/albumin (ALB)-positive cells of the hUCMSC group were less than the AHH group in the recipient liver. Higher values of human ALB in the serum of mice-transplanted AHHs were determined in comparison with levels in mice-transplanted hUCMSCs. The analysis of mouse serum cytokine levels showed that hUCMSC transplantation was even more effective than treatment with AHHs and successfully down-regulated the systemic inflammatory cytokines such as interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, IL-6, IL-10, and IL-1 receptor antagonist (IL-1RA). Furthermore, paracrine effects produced by hUCMSCs were identified by indirect coculture with damaged mouse hepatocytes (MHs) induced by CCl4. Coculture with hUCMSCs significantly increased the viability, ALB secretion of damaged MHs, and greatly enhanced the regeneration of MHs in vitro when compared with AHHs. These data suggest that direct transplantation of native hUCMSCs can rescue ALF and repopulate livers of mice through paracrine effects to stimulate endogenous liver regeneration rather than hepatic differentiation for compensated liver function, which is the primary effect of AHHs. Thus, hUCMSCs can be a potential alternative source of AHHs for cell therapy of ALF and eliminate the shortage of hepatocytes.

Characterization and Hepatogenic Differentiation of Mesenchymal Stem Cells from Human Amniotic Fluid and Human Bone Marrow: a Comparative Study.

Immunomodulative Effects of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells in Vivo and in Vitro

Committed-differentiation of Transplanted Bone Derived Mesenchymal Stem Cells and Their Potential to Amend Damaged Liver Functions: in Vivo Experiment with Mice

Isolation and identification of human fetal bone-derived mesenchymal stem cells and their differentiation to hepatocyte like cells

Comparative Study of in vitro Hepatic Differentiation Capability of Two Different Stem Cell Subsets Derived from Bone-marrow

Hepatic Differentiation Capability of Rat Bone Marrow-Derived Mesenchymal Stem Cells and Hematopoietic Stem Cells

Human Amniotic Fluid-Derived Stem Cells Can Differentiate into Hepatocyte-Like Cells in Vitro and in Vivo

Menstrual Blood-Derived Mesenchymal Stem Cells Differentiate into Functional Hepatocyte-Like Cells

Differentiation of mouse bone marrow mesenchymal stem cells into hepatocyte-like cells in vitro

Comparison of the Neural Differentiation Potential of Human Mesenchymal Stem Cells from Amniotic Fluid and Adult Bone Marrow

Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation.

Early Homing Behavior of Stro-1− Mesenchyme-Like Cells Derived from Human Embryonic Stem Cells in an Immunocompetent Xenogeneic Animal Model

Transdifferentiation of Mesenchymal Stem Cells Derived from Human Fetal Lung to Hepatocyte-Like Cells.

Transcriptome Profiling Reveals Distinct Phenotype Of Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cells

Rat Bone Marrow Mesenchymal Stem Cells Differentiate into Hepatocytes in Vitro.

In vitro study of hepatocyte differentiation from bone marrow mesenchymal stem cells

Mesenchymal Stem Cells Differentiate into Hepatocyte-Like Cells under Different Induction Systems in Hepatitis B Patients with Liver Failure

Differentiation of Human Umbilical Cord Mesenchymal Stromal Cells into Low Immunogenic Hepatocyte-Like Cells

[Proliferative Capacity of Mesenchymal Stem Cells from Human Fetal Bone Marrow and Their Ability to Differentiate into the Derivative Cell Types of Three Embryonic Germ Layers].

[Isolation, Culture and Multipotent Differentiation of Mesenchymal Stem Cells from Human Fetal Livers].

Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro.